It is anticipated that the global pregnancy point of care testing market would generate US$ 2.33 billion in sales, up from its current value of US$ 1.5 billion in 2023. Over the next 10 years, the demand for point-of-care pregnancy testing is expected to increase globally at a 4.5% CAGR. The Pregnancy Point of Care Testing (POCT) Market refers to the market for medical diagnostic tests that are performed at or near the point of care, typically at the bedside or in a physician’s office, and used to confirm or rule out pregnancy.
This market is driven by the increasing demand for accurate and convenient diagnostic testing methods for pregnancy, as well as the rising awareness among women about the importance of prenatal care. The market includes various types of POCT devices, including urine-based tests, blood-based tests, and others. The global pregnancy POCT market is expected to experience significant growth over the next few years, driven by increasing demand for these tests in developing countries, rising awareness about the benefits of early pregnancy diagnosis, and advancements in technology.
Download Free Sample Copy of this Report – https://www.factmr.com/connectus/sample?flag=S&rep_id=3560
However, the market also faces some challenges, such as the high cost of these tests and the lack of skilled healthcare professionals to perform them in some regions. Additionally, the COVID-19 pandemic has also had a significant impact on the market, with disruptions in supply chains and changes in healthcare policies affecting demand for these tests.
Key Takeaways from Pregnancy Point of Care Testing Market Survey
- Sales of strips/dipsticks and card-based pregnancy test kits are anticipated to remain high.
- Urine-based pregnancy test kits are expected to emerge as the most preferred sample type.
- Pharmacies and drugstores are projected to account for maximum sales of pregnancy point of care testing products, followed by online retail channels.
- The U.S. is projected to dominate the North America market owing to the presence of key market players and high awareness regarding women’s health and pregnancy.
- South Asia will emerge as a lucrative pocket over the forecast period due to increasing preference for home monitoring devices in South Asia counties.
Reginal Analysi
- North America: The North American market is expected to dominate the global Pregnancy POCT market owing to the high adoption rate of these tests, favorable reimbursement policies, and the presence of major market players in the region.
- Europe: The European market is also expected to show significant growth due to increasing awareness and adoption of pregnancy POCT tests, rising disposable income, and supportive healthcare policies.
- Asia-Pacific: The Asia-Pacific region is expected to be the fastest-growing market due to increasing government initiatives for improving healthcare infrastructure and rising awareness of prenatal care. Additionally, increasing demand for rapid and accurate diagnosis in the region is expected to boost market growth.
- Latin America: The Latin American market is also expected to show significant growth due to rising healthcare expenditure and government initiatives to improve healthcare infrastructure.
- Middle East & Africa: The Middle East and African market is expected to grow at a moderate pace due to increasing government initiatives to improve healthcare infrastructure and rising awareness about prenatal care.
Get Customization on this Report for Specific Research Solutions – https://www.factmr.com/connectus/sample?flag=RC&rep_id=3560
Competitive Landscape
Leading players operating in the global pregnancy point of care testing market are improving their product portfolio by investing in strategic collaborations, mergers, and acquisitions. Besides this, collaborations with regional healthcare authorities and non-governmental welfare organizations are anticipated to assist manufacturers in establishing a firm foothold in the market.
For instance:
- In July 2018, a U.S. based company active in point of care testing market, NOW Diagnostics Inc. announced the acquisition of Cellmic LLC, a manufacturer of mobile phone-based holographic imaging and diagnostics in the U.S. Through this acquisition, the company aimed at positioning itself as a key player in the diagnostic and mobile space.
Key Players in the Pregnancy Point of Care Testing Market Include:
- Abbott Laboratories
- Quidel Corporation
- Prestige Brands Holdings
- Swiss Precision Diagnostics (SPD) GmbH
- Church & Dwight Co., Inc.
- BIOSYNEX SA
- EKF Diagnostics Holdings plc
- NOW Diagnostics Inc
- NG BIOTECH SAS
- ulti med Products (Deutschland) GmbH
- Procter & Gamble Co.
- Piramal Enterprises
- bioMérieux SA
- Atlas Medical UK
- Home Health (UK) Ltd
For in-depth competitive analysis, Buy Now – https://www.factmr.com/checkout/3560
Key Questions Covered in the Pregnancy Point of Care Testing Market
- What is the size of the global Pregnancy POCT market, and what are the growth trends and drivers for the market?
- What are the different types of POCT devices used for pregnancy testing, and what are their advantages and disadvantages?
- What are the major market players in the Pregnancy POCT market, and what are their strategies for growth and market positioning?
- What are the regulatory and reimbursement policies for Pregnancy POCT tests in different regions, and how do they impact market growth?
- What are the major market trends and challenges in the Pregnancy POCT market, and how are they likely to impact market growth in the future?
Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
